Germany Sov/Sub-Sov Debt ETF Proshares (GGOV) 35.62

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Germany Sov/Sub-Sov Debt ETF Proshares (GGOV) 35.62 $GGOV

Kill Debt To Make Debt
Joseph Calhoun - Seeking Alpha - Sat Mar 21, 7:06AM CDT
By Jeffrey P. Snider In the days before 2007, the idea of monetary "stimulus" was relatively straight-forward in theory as well as (seemingly) practice. A central bank declared that it would reduce an interest rate target and the...
BUNT: 52.90 (-0.39), EU: 20.54 (-0.08), GGOV: 35.62 (-1.63), BUNL: 28.13 (+0.13)

Bill Gross: Going To The Dogs
Bill Gross - Seeking Alpha - Sun Mar 15, 3:53AM CDT
If you were a dog, what kind would you be? I can't say I've thought about it a lot myself, but it is an interesting, possibly introspective question considering the theory that many dog owners pick a breed that looks or perhaps acts like themselves....
1 Comment
SPY: 210.41 (+0.91), BUNT: 52.90 (-0.39), DIA: 180.96 (+1.30), EU: 20.54 (-0.08), XLF: 24.71 (+0.24), FXF: 99.75 (+1.49), GGOV: 35.62 (-1.63), UDN: 21.61 (+0.26), TLT: 131.51 (+0.69), UUP: 25.82 (-0.35), BUNL: 28.13 (+0.13)

What Negative Interest Rates And Quantitative Easing Are Doing To The Stock Market
Rodney Johnson - at Seeking Alpha - Sun Mar 15, 2:58AM CDT
If I asked you to lend me money for five years, what rate of interest would you charge? 5%? 3%? How about zero? Does zero work for you? It works for me. Or even better, how about you lend me money, and then at the end of the loan you pay me ...
BUNT: 52.90 (-0.39), EU: 20.54 (-0.08), FXE: 106.32 (+1.63), GGOV: 35.62 (-1.63), FXF: 99.75 (+1.49), AAPL: 125.90 (-1.60), BUNL: 28.13 (+0.13)

European Rates Converge In Wake Of QE
Markit - Seeking Alpha - Wed Mar 11, 11:45AM CDT
The ECB QE policy has seen yield curves in Europe flatten across the board, although the ECB's pledge to limit purchase to assets priced above -0.2% has caused a price floor. The ECB's QE programme commenced Monday, which European bonds investors...
ADRU: 23.48 (+0.56), VGK: 55.87 (+1.41), FEZ: 39.29 (+1.10), DBEU: 29.69 (+0.31), FEEU: 115.60 (+6.09), EURL: 34.21 (+2.36), FIEU: 119.23 (+5.93), EZU: 39.08 (+1.08), FEP: 31.62 (+0.65), FEUZ: 32.88 (+0.78), EU: 20.54 (-0.08), IEUR: 46.52 (+1.12), GGOV: 35.62 (-1.63), UPV: 48.39 (+2.14), FEU: 36.03 (+0.69), HEDJ: 66.87 (+0.74), EPV: 54.01 (-2.86), SBEU: 25.31 (-0.10), IEV: 45.29 (+1.11), BUNT: 52.90 (-0.39), DBEZ: 29.79 (+0.37), ESTX: 47.80 (+1.54), HEZU: 29.31 (+0.39), BUNL: 28.13 (+0.13)

Yields tumble alongside stocks
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 9:31AM CDT

TLH: 138.81 (+0.75), DLBL: 76.53 (-0.18), TLO: 75.71 (+0.46), UBT: 87.85 (+1.14), TLT: 131.51 (+0.69), TBT: 41.44 (-0.47), DLBS: 19.31 (-0.39), ZROZ: 128.28 (+0.79), TTT: 35.27 (-0.59), TYBS: 21.87 (+0.11), ITLY: 31.50 (+0.12), TENZ: 87.46 (+0.56), EDV: 132.00 (+0.92), ITLT: 65.98 (-0.71), GGOV: 35.62 (-1.63), TMV: 26.26 (-0.43), LBND: 60.76 (+0.90), SBND: 4.17 (-0.06), TBF: 23.84 (-0.13), TAPR: 29.23 (-0.27), BUNT: 52.90 (-0.39), VGLT: 80.81 (+0.37), TMF: 96.98 (+1.44), PLW: 33.61 (+0.10), GOVT: 25.50 (+0.04), BUNL: 28.13 (+0.13)

German industrial production improves
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 3:46AM CST

EWG: 30.26 (+0.79), DAX: 28.65 (+0.87), BUNT: 52.90 (-0.39), DBGR: 28.93 (+0.24), FGM: 39.09 (+0.88), DXGE: 31.68 (+0.38), QDEU: 58.13 (+1.49), EWGS: 40.17 (+0.98), GGOV: 35.62 (-1.63), HEWG: 28.80 (+0.33), BUNL: 28.13 (+0.13)

German factory orders decline
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 4:13AM CST

EWG: 30.26 (+0.79), DAX: 28.65 (+0.87), BUNT: 52.90 (-0.39), DBGR: 28.93 (+0.24), FGM: 39.09 (+0.88), DXGE: 31.68 (+0.38), QDEU: 58.13 (+1.49), EWGS: 40.17 (+0.98), GGOV: 35.62 (-1.63), HEWG: 28.80 (+0.33), BUNL: 28.13 (+0.13)

The Draghi Derangement: $2 Trillion Euro Government Bonds Trading At Negative Yield
David Stockman - Seeking Alpha - Tue Mar 03, 7:56AM CST
That investors anywhere in this age of fiscal profligacy would pay to own the notes and bonds of sovereign states is a testament to the financial deformations of modern central banking. But the fact that nearly $2 trillion of debt issued by European...
ULE: 15.74 (+0.44), ITLY: 31.50 (+0.12), URR: 17.25 (+0.55), ITLT: 65.98 (-0.71), EU: 20.54 (-0.08), EUO: 26.67 (-0.88), GGOV: 35.62 (-1.63), BUNT: 52.90 (-0.39), FXE: 106.32 (+1.63), ERO: 41.04 (+0.73), EUFX: 44.64 (-0.66), DRR: 62.18 (-1.82), BUNL: 28.13 (+0.13)

Bond Markets Anticipate European Inflation
Markit - Seeking Alpha - Thu Feb 19, 7:56AM CST
Mario Draghi's aim of kick starting inflation across the eurozone seems to be paying off, according to recent activity in the bond markets. Kick starting inflation was one of the cornerstone aims of the recent ECB QE steps. The prospects of a...
BUNT: 52.90 (-0.39), EU: 20.54 (-0.08), GGOV: 35.62 (-1.63), BUNL: 28.13 (+0.13)

Europe heads higher after GDP data
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 2:59AM CST

EWG: 30.26 (+0.79), DAX: 28.65 (+0.87), BUNT: 52.90 (-0.39), DBGR: 28.93 (+0.24), FGM: 39.09 (+0.88), DXGE: 31.68 (+0.38), EWQ: 26.42 (+0.70), QDEU: 58.13 (+1.49), EWGS: 40.17 (+0.98), GGOV: 35.62 (-1.63), HEWG: 28.80 (+0.33), BUNL: 28.13 (+0.13)

Move To Risk Averse Investments Impacting Securities
Learn Bonds - Seeking Alpha - Mon Feb 09, 3:45PM CST
Last week, the yield on the 10-year German bund fell below the yield on the 10-year Japanese government bond. On Tuesday, February 3, the yield on this German bund closed at 0.35 percent. The yield on the same maturity Japanese bond closed at 0.37...
BUNT: 52.90 (-0.39), EU: 20.54 (-0.08), GGOV: 35.62 (-1.63), BUNL: 28.13 (+0.13)

The German 10-Year Bund Effectively A Call Option At 30 Basis Points
EconMatters - at Seeking Alpha - Sun Feb 01, 10:23AM CST
Bonds are not Stocks On Friday, the German 10-year Bund yield touched the 0.30 mark or 30 basis points, yeah that's right the same instrument that was yielding 90 basis points in November of last year, 140 basis points in May 2014, and 195 basis...
BUNT: 52.90 (-0.39), GGOV: 35.62 (-1.63), BUNL: 28.13 (+0.13)

UK 10-Year Bond Hits All-Time Low
Learn Bonds - Seeking Alpha - Fri Jan 30, 5:33PM CST
The United Kingdom’s ten-year gilt hit an all-time low in trading on Thursday as the effects of the European Central Bank’s quantitative easing program appears to be taking hold of the country’s debt market. Yields hit a low of...
BUNT: 52.90 (-0.39), EU: 20.54 (-0.08), GGOV: 35.62 (-1.63), BUNL: 28.13 (+0.13)

Long-term Treasury yields lower after soft GDP print
Seeking Alpha - at Seeking Alpha - Fri Jan 30, 7:36AM CST

TLH: 138.81 (+0.75), DLBL: 76.53 (-0.18), TLO: 75.71 (+0.46), TENZ: 87.46 (+0.56), EDV: 132.00 (+0.92), UBT: 87.85 (+1.14), GGOV: 35.62 (-1.63), TLT: 131.51 (+0.69), TBT: 41.44 (-0.47), TMV: 26.26 (-0.43), DLBS: 19.31 (-0.39), LBND: 60.76 (+0.90), ZROZ: 128.28 (+0.79), SBND: 4.17 (-0.06), TBF: 23.84 (-0.13), BUNT: 52.90 (-0.39), TTT: 35.27 (-0.59), VGLT: 80.81 (+0.37), TYBS: 21.87 (+0.11), BUNL: 28.13 (+0.13), TMF: 96.98 (+1.44)

ECB Monetary Dominance With 1.14 Trillion Euro QE For March 2015 To September 2016
FX Analyst - at Seeking Alpha - Sun Jan 25, 11:41AM CST

ULE: 15.74 (+0.44), ITLY: 31.50 (+0.12), URR: 17.25 (+0.55), ITLT: 65.98 (-0.71), EU: 20.54 (-0.08), EUO: 26.67 (-0.88), GGOV: 35.62 (-1.63), BUNT: 52.90 (-0.39), FXE: 106.32 (+1.63), ERO: 41.04 (+0.73), EUFX: 44.64 (-0.66), DRR: 62.18 (-1.82), BUNL: 28.13 (+0.13)

European bond yields tumble on ECB QE
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 8:38AM CST

ITLY: 31.50 (+0.12), BUNT: 52.90 (-0.39), ITLT: 65.98 (-0.71), IGOV: 92.00 (+1.25), BNDX: 54.07 (+0.05), EU: 20.54 (-0.08), GGOV: 35.62 (-1.63), BWX: 53.13 (+0.64), TLT: 131.51 (+0.69), BUNL: 28.13 (+0.13)

Safety And Quality To Beat Deflation In 2015
Badre Bouarich - at Seeking Alpha - Thu Jan 15, 9:17AM CST

BUNT: 52.90 (-0.39), GLD: 113.57 (+1.28), UUPT: 29.72 (-0.06), GGOV: 35.62 (-1.63), UDN: 21.61 (+0.26), USDU: 28.43 (-0.39), FORX: 42.90 (-0.29), UUP: 25.82 (-0.35), UDNT: 10.33 (-0.15), BUNL: 28.13 (+0.13)

Record low for Germany's 10-year Bund yield
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 7:21AM CST

BUNT: 52.90 (-0.39), GGOV: 35.62 (-1.63), BUNL: 28.13 (+0.13)

10-year Treasury yield dips below 2%
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 6:16AM CST

JGBL: 21.48 (-0.39), TLH: 138.81 (+0.75), DLBL: 76.53 (-0.18), TLO: 75.71 (+0.46), JGBT: 26.07 (+0.16), JGBS: 18.17 (+0.02), BNDX: 54.07 (+0.05), UBT: 87.85 (+1.14), TLT: 131.51 (+0.69), TBT: 41.44 (-0.47), DLBS: 19.31 (-0.39), ZROZ: 128.28 (+0.79), TTT: 35.27 (-0.59), TYBS: 21.87 (+0.11), BWX: 53.13 (+0.64), ITLY: 31.50 (+0.12), TENZ: 87.46 (+0.56), ITLT: 65.98 (-0.71), EDV: 132.00 (+0.92), GGOV: 35.62 (-1.63), TMV: 26.26 (-0.43), LBND: 60.76 (+0.90), SBND: 4.17 (-0.06), TBF: 23.84 (-0.13), BUNT: 52.90 (-0.39), IGOV: 92.00 (+1.25), VGLT: 80.81 (+0.37), JGBB: 49.31 (-0.03), JGBD: 14.88 (-0.22), TMF: 96.98 (+1.44), BUNL: 28.13 (+0.13)

Treasurys rally as Greek vote spurs flight to safety
Seeking Alpha - at Seeking Alpha - Mon Dec 29, 11:56AM CST

TLH: 138.81 (+0.75), TBX: 29.67 (-0.08), DFVS: 32.05 (-0.45), TBZ: 29.05 (-0.17), DFVL: 64.14 (+1.16), DLBL: 76.53 (-0.18), TLO: 75.71 (+0.46), UBT: 87.85 (+1.14), TLT: 131.51 (+0.69), TBT: 41.44 (-0.47), DLBS: 19.31 (-0.39), ZROZ: 128.28 (+0.79), ITE: 60.43 (+0.09), TYO: 17.21 (-0.19), TTT: 35.27 (-0.59), SCHR: 54.29 (+0.17), GSY: 50.03 (+0.03), SYTL: 85.70 (-2.97), TYBS: 21.87 (+0.11), FIVZ: 80.31 (unch), VGIT: 65.27 (+0.21), DTYL: 76.15 (+1.46), IEI: 123.91 (+0.39), TYD: 47.64 (+0.71), PST: 23.46 (-0.15), IEF: 108.31 (+0.44), UST: 58.13 (+0.46), TENZ: 87.46 (+0.56), EDV: 132.00 (+0.92), DTYS: 19.36 (-0.62), GGOV: 35.62 (-1.63), TYNS: 30.32 (-0.09), TMV: 26.26 (-0.43), LBND: 60.76 (+0.90), SBND: 4.17 (-0.06), TBF: 23.84 (-0.13), BUNT: 52.90 (-0.39), VGLT: 80.81 (+0.37), TMF: 96.98 (+1.44), BUNL: 28.13 (+0.13)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Promising Interim Findings from Medicus Pharma's BCC Study

Updated Category News Views 164

Positive Interim Analysis from Medicus Pharma Ltd Medicus Pharma Ltd. (NASDAQ: MDCX) has recently shared exciting interim results from its SKNJCT-003 Phase 2 clinical study, which focuses on a non-invasive approach to treat basal cell carcinoma (BCC) of the skin. This news marks a significant milestone as the company aims to revolutionize the treatment options available...

Continue Reading
DroneShield's Immediate Response Kit Wins Platinum Award for Innovation

Updated Category News Views 161

DroneShield's Immediate Response Kit Gains Recognition for Innovation DroneShield has recently been awarded the prestigious Platinum Award for Innovation by Military and Aerospace Electronics, showcasing its Immediate Response Kit (IRK) as a cornerstone in drone detection and defeat technology. This award is a testament to the exceptional capabilities of the IRK, which...

Continue Reading
Jefferies Holds ABB Rating; Analysts Assess Mixed Results

Updated Category News Views 65

Jefferies Maintains Hold Rating on ABB Stock Jefferies recently continued its Hold rating for ABB Ltd (NYSE: ABB) and set a price target of CHF50.00, following the company's third-quarter performance report. The report showcased a mixed array of results, with certain metrics outperforming expectations while others showed disappointing trends. During the third quarter, ABB...

Continue Reading
Surgical Clips Market Projected to Reach $1.8 Billion Soon

Updated Category News Views 211

Overview of the Surgical Clips Market Recent analysis of the surgical clips market reveals an impressive valuation of USD 655.9 million in 2023, with projections indicating a potential growth to USD 1.8 billion by 2032. This remarkable increase is attributed to a compound annual growth rate (CAGR) of 11.9% from 2024. Understanding Surgical Clips and Their Importance...

Continue Reading
Public Disclosure of Opening Position by Keywords Studios Plc

Updated Category News Views 74

Public Opening Position Disclosure for Keywords Studios Plc This document provides important information about a public opening position disclosure related to Keywords Studios Plc. It includes details about individuals or entities holding 1% or more of relevant securities. This disclosure is made in accordance with Rule 8.3 of the Takeover Code, which ensures that all...

Continue Reading